Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muratori, L
Right arrow Articles by Bianchi, F B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muratori, L
Right arrow Articles by Bianchi, F B
GUT 1998;42:721-726 ( May )

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

L Muratori, M Cataleta, P Muratori, M Lenzi, F B Bianchi

Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy

Correspondence to: Dr Luigi Muratori, Department of Internal Medicine, Cardioangiology and Hepatology, Policlinico S Orsola, via Massarenti 9, 40138 Bologna, Italy.

Accepted for publication 18 December 1997

Background---Liver/kidney microsomal antibody type 1 (LKM1) and liver cytosol antibody type 1 (LC1) are the serological markers of type 2 autoimmune hepatitis (AIH).
Aims---Since LKM1 and LC1 react against two distinct liver specific autoantigens (cytochrome P450IID6 (CYP2D6) and a 58 kDa cytosolic polypeptide respectively), the aim was to see whether LKM1 and LC1 concentrations correlate with liver disease activity.
Patients---Twenty one patients with type 2 AIH were studied.
Methods---All sera were tested by indirect immunofluorescence, counterimmunoelectrophoresis, and immunoblotting visualised by enhanced chemiluminescence. To evaluate LKM1 and LC1 levels, the 50 kDa microsomal reactivity (corresponding to CYP2D6) and the 58 kDa cytosolic reactivity were quantified by densitometric analysis.
Results---Seven patients were positive for LKM1, nine for LC1, and five for both. Serial serum samples at onset and during immunosuppressive treatment were analysed in 13 patients (four positive for LKM1, six positive for LC1 and three positive for both). During remission, LKM1 concentration remained essentially unchanged in six of seven patients, and decreased in only one. Conversely, in two of nine patients, LC1 was completely lost, and, in the remaining seven, LC1 concentration was reduced by more than 50%. After immunosuppression tapering or withdrawal, flare ups of liver necrosis ensued with increasing LC1 concentration, but not LKM1.
Conclusions---LC1 concentration, at variance with that of LKM1, parallels liver disease activity, and its participation in the pathogenic mechanisms of liver injury can be hypothesised.
(GUT 1998;42:721-726)

Keywords: autoantibodies;  immunoblotting;  LKM1;  LC1;  immunosuppression

© 1998 by Gut


This article has been cited by other articles:


Home page
 QJMHome page
R. Ferrari, G. Pappas, D. Agostinelli, P. Muratori, L. Muratori, M. Lenzi, G. Verucchi, F. Cassani, F. Chiodo, and F.B. Bianchi
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type
QJM, July 1, 2004; 97(7): 407 - 412.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & British Society of Gastroenterology